Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



4-Star Small-Caps Set to Soar: Hi-Tech Pharmacal

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, specialty drug maker Hi-Tech Pharmacal (Nasdaq: HITK  ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Hi-Tech and see what CAPS investors are saying about the stock right now.

Hi-Tech facts

Headquarters (founded)

Amityville, N.Y. (1982)

Market Cap

$435.2 million



Trailing-12-Month Revenue

$225.8 million


Chairman/CEO David Seltzer (since 1998)
CFO William Peters (since 2004)

Return on Equity (average, past 3 years)



$92.3 million/$1.5 million


Mylan (Nasdaq: MYL  )
Teva Pharmaceuticals
Watson Pharmaceuticals

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 92% of the 222 members who have rated Hi-Tech believe the stock will outperform the S&P 500 going forward.

Just last week, one of those Fools, arrowboy, tapped Hi-Tech as a particularly attractive growth opportunity:

Using Peter Lynch motivated stock screen found this gem. Good growth in revenue and EPS. P/E less than half the [three-year EPS growth rate]. Still small enough to grow substantially at <$500M mkt cap. The single negative is the high institutional ownership (>60%) which brings the analysts following as well.

If you want market-beating returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its strong four-star rating, Hi-Tech may not be your top choice.

We've found another growth play we are incredibly excited about -- excited enough to dub it "The Only Stock You Need to Profit from the NEW Technology Revolution." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Fool contributor Brian Pacampara has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2057605, ~/Articles/ArticleHandler.aspx, 10/26/2016 10:01:30 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,083.05 -86.22 -0.47%
S&P 500 2,132.79 -10.37 -0.48%
NASD 5,255.10 -28.30 -0.54%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/26/2016 9:45 AM
AGN $225.68 Up +0.39 +0.17%
Allergan CAPS Rating: ****
HITK.DL $0.00 Down +0.00 +0.00%
Hi-Tech Pharmacal CAPS Rating: *****
MYL $38.15 Down -0.53 -1.37%
Mylan CAPS Rating: ***